GAD1 and type 1 diabetes mellitus: De Filette et al. (de Filette et al., 2019) demonstrated that at least one islet autoantibody was positive in 53% (47/88) of the analyzed patients with ICI-induced T1DM, while the GAD antibody was the most positive in 51% of patients.